Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Injectable Naltrexone Treatment of Alcohol Dependence in Serious Mental Illness (SMI): An Open Prospective Pilot Trial

NCT00453609 is registered in ClinicalTrials.gov with State University of New York - Upstate Medical University as lead sponsor.

NCT NCT00453609
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00453609 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Injectable Naltrexone Treatment of Alcohol Dependence in Serious Mental Illness (SMI): An Open Prospective Pilot Trial
Lead sponsor
State University of New York - Upstate Medical University
Phase
Phase 4
Overall status
Completed
Start date
April 30, 2007
Completion date
October 31, 2008
Enrollment
15 (actual)
Sites
3

Conditions

As the registry lists them; a condition with its own page is linked.

alcohol dependence, bipolar disorder, schizoaffective disorder, schizophrenia